ARKEMA: business up in the fourth quarter

  •   26/02/2021 - 17h06
  •   DEHOUI Lionel

The French chemical group Arkema has unveiled its financial results for the year 2020. Its activity fell sharply over the whole of last year, due to the health crisis. However, the company ended the year with a strong performance in the fourth quarter.

72% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money. This is an advert for trading CFDs on Plus500
ARKEMA: business up in the fourth quarter

Arkema's 2020 results driven by growth in Q4

The French chemical group Arkema's year-end results for 2020 were marked by the best results recorded in the fourth quarter. Indeed, the company's activity in the last quarter experienced a strong rebound. As regards the company's overall performance over the whole of last year, this resulted in an Ebitda of 1.182 billion euros.

1.182 billion, a decline of 18.9%. The group's EBITDA margin was 15%. Arkema also reported a decline in sales. Sales fell by 8% at constant exchange rates to 7.9 billion euros. 7.9 billion, reflecting the difficulties encountered by the company over the past year.

Indeed, the health crisis linked to the coronavirus pandemic is the main cause of this downturn. In particular, it has impacted global demand, causing a drop in the Group's revenues. On the other hand, Arkema's results were better in the fourth quarter. Over this period alone, the company experienced growth in sales.

They increased by 2.1% at constant scope of business and exchange rates. Also, the French group recorded almost stable Ebitda. 289 million for the last quarter as a whole.


Arkema's outlook for 2021

Arkema also presented its objectives for this new year. Thus, the company announced a return of the dividend to 2.50 euros per share. 2.50 per share, which will bring it back to its pre-Covid level. In addition, the French chemicals group announced the launch of its share buyback plan, which is worth around 300 million euros.

300 million. Its implementation should begin once the PMMA divestment project has been completed. In 2021, Arkema also expects to record an increase in its Ebitda based on Specialty Materials. It should be noted that this activity generated 82% of the Group's sales last year.

In a still volatile environment that does not take into account a resurgence of the pandemic, the company plans to achieve, at constant parity, growth in Specialty Materials EBITDA in 2021. It is targeting a 10% increase compared to last year (2020). For Intermediates, the group expects to remain stable at constant parity and scope (closing of PMMA expected mid-2021).


About Arkema

Arkema is a French company specializing in the chemical industry. It is particularly active in specialty chemicals and performance materials. The Company was created in 2004 and is headquartered in Colombes, France. It was created through a spin-off from Total.

The company made its first stock market listing in 2005. The Group's shares are listed on Euronext Paris. In addition, Arkema has more than 20 500 employees in 55 countries around the world. This reflects the breadth of its international operations.